The experiments in this report involve the following series of reactions which were previously demonstrated with purified enzyme preparations from Neurospora crassa: thymidine A-thymine ribonucleoside bX thymine X-5-hydroxymethyluracil A-5-formyluracil eA uracil-5-carboxylic acid I uracil. The evidence for some of the reactions occurring in vivo has been incomplete and for others totally lacking. In this paper intact cells of Neurospora are shown to be capable of converting the substrates of each of the reactions to the corresponding products. Studies are described which were carried out in vivo and in vitro with the pyrimidineless strains pyr-4,uc-1,uc-2 and pyr-4,uc-1,uc-3, developed by Williams and Mitchell. The results reported in the present paper indicate that the uc-2 mutation affects the pyrimidine deoxyribonucleoside 2-hydroxylase (reaction a) and the uc-3 mutation affects thymine 7-hydroxylase (reactions c. d, and e). Evidence is presented for the 2-hydroxylase reaction being the major, if not only, way by which Neurospora can initiate the conversion of thymidine to the pyrimidines of nucleic acids and for the 2-hydroxylation of thymidine and deoxyuridine being catalyzed by the same enzvme. Deoxycytidine was shown not be be hydroxvlated in intact cells but instead deaminated to deoxyuridine, which in turn was converted to uridine. Further studies with the uc-3-carrying strain showed that an enzyme other than thymine 7-hydroxylase can also convert 5-formyluracil to uracil-5-carboxylic acid.
showed that 5-hydroxymethyluracil and 5-formyluracil accumulated in the mycelia of Neurospora crassa during the conversion of thymidine to uracil and cytosine of ribonucleic acid in a process which does not involve fragmentation of the pyrimidine ring. They proposed a pathway for pyrimidine catabolism in which the methyl group of thymidine is removed in a series of oxidative steps (6) . Subsequently, purified enzyme preparations were obtained from Neurospora which catalyzed the reactions shown in Fig 1 ( for reviews see reference 3 and 0. Hayaishi, M. Nozaki. and M. T. Abbott, in P. Boyer (ed.), The enzymes, in press). Further evidence for 5-hydroxymethyluracil and 5-formyluracil being intermediates in the pathway has come from studies by Williams and Mitchell (18) who have developed several mutants of the pyrimidineless strain pyr-4. The pyr-4 strain can utilize uridine or cytidine as a sole pyrimidine source but not thymidine, thymine, 5-hydroxymethyluracil, or 5-formyluracil, although the latter compounds can be utilized if ' Present address: Chemistry Department, University of San Diego, San Diego, Calif. 92110. growth is initiated with uridine or cytidine (5, 18) . The pyr-4,uc-1 strain can utilize thymidine, thymine, 5-hydroxymethyluracil, or 5-formyluracil as a sole pyrimidine source, and Williams and Mitchell have suggested that the uc-1 mutation affects a gene which controls the activity of one or more enzymes involved in the pathway. The pyr-4,uc-1,uc-2 strain was thought (18) to be defective in a pyrimidine deoxynucleosidase since this strain could utilize thymine, 5-hydroxymethyluracil. or 5-formyluracil, but not thymidine, deoxyuridine, or deoxycytidine as a pyrimidine source. Moreover, it was suggested (16) that the pyrimidine deoxyribonucleoside 2-hydroxylation step (Fig. 1, reaction a) or the subsequent hydrolysis step (reaction b) might instead be affected in the uc-2-carrying strain. The uc-3 mutation was thought to affect the conversion of 5-hydroxymethyluracil to 5-formyluracil and possibly of thymine to 5-hydroxymethyluracil but not of 5-formyluracil to uracil-5-carboxylic acid, since the pyr-4,uc-l,uc-3 strain could grow on medium supplemented with 5-formyluracil or uracil but not when the supplement was thymidine, thymine, or 5-hydroxymethyluracil (18 and thymine 7-hydroxylase (1.14.11.6), respectively.
MATERIALS AND METHODS Strains. N. crassa wild-type strain (1A) and two pyrimidineless triple mutants, pyr-4,uc-1,uc-2 and pyr-4,uc-1,uc-3, were used. The triple mutants were obtained from William M. Thwaites (San Diego State University).
Media and chemicals. The cell-free studies were carried out with extracts from Neurospora grown on Fries minimal medium (8), supplemented with uridine (0.2 g/liter) for mutants. Westergaard-Mitchell (17) medium was used for growth tests with mutants as described by Williams and Mitchell since it facilitates pyrimidine utilization (18) . In experiments in which radioactive substrates were incubated with mycelial pad-sections, Fries medium (supplemented with uridine for mutants) was used in the studies of the 2'-hydroxylase (Fig. 1, reaction a) The sources of the radioactive compounds were previously described (10-12, 14, 16) . The specific activities (curies per mole) of the pyrimidines and nucleosides used are as follows: 3.0 for [2-"C ]thymine ribonucleoside, [2-"Cluridine, [2- [2- 14C ]uracil-5-carboxylic acid, and [2-"C ]deoxycytidine; 2.0 for [2-"C]thymidine and [2-"C]deoxyuridine; 4.0 for "4C and 16.0 for 'H in thymidine which contained 'H in position 6 of the pyrimidine ring and which was uniformly labeled with "4C. All other fine chemicals were obtained from commercial sources as previously described (10, 11 ing of a solution of 25 gliters, which contained the radioactive substrate, with the medium adhering to the pad-section. Both the preincubation and incubation were carried out in an atmosphere equilibrated with medium. The incubation was concluded after 3 h by adding 1 ml of 80% ethanol. Appropriate chromatographic marker compounds were added and five 1.5-ml portions of 80% ethanol were used to transfer this mixture containing pad-section and media to a chromatographic applicator tube, from which the ethanolic extracts were quantitatively siphoned onto chromatographic paper. Two-dimensional paper chromatography was carried out (4, 14) at 28 C with solvent systems which have been previously described. The separated pyrimidines and nucleosides on the developed chromatograms were outlined under ultraviolet light, and the alignment of radioactive compounds with marker compounds was checked with radioautography. (2) . To make radioactivity measurements, portions of the chromatograms which contained the separated compounds were either centered under a thin-window Geiger tube or cut out, added to scintillation fluid and placed in a Packard Tri-Carb scintillation counter at 0 C with the filter paper lying flat on the bottom of the vial (14 (9) .
Cell-free preparations and enzymatic assays. The preparation of crude extracts (11) and the purification scheme to which they have been subjected (9, 10) have been previously described. Thymine 7-hydroxylase and pyrimidine deoxyribonucleoside 2'-hydroxylase are dioxygenases which catalyze the following type of reaction:
Fe'+ S + 02 + a-ketoglutarate SO reducing agent + succinate + CO2 (1) The standard incubation mixture which was used to assay for these enzymes consisted of 0.1 ml of enzyme preparation and 0.1 ml of 0.02 mM sodium phosphate buffer, pH 7.5, which contained subtrates and cofactors so that the final incubation mixture was 0.75 mM in radioactive pyrimidine or deoxyribonuceloside, 1 mM in a-ketoglutarate, 1 mM in ferrous sulfate, 1 mM in ascorbate, and 0.4 mg/ml in catalase. In the assay for the 7-hydr'oxylase, the radioactive pyrimi- or [2-14C Jdeoxyuridine was used. The standard incubation mixture, with the appropriate radioactive pyrimidine, was also used to assay for reactions d and e, Fig. 1 . The details of how the incubations were carried out, how the radioactive products of the incubation mixtures were chromatographically separated, and how the radioactivity measurements were made have been described (9, 10) .
RESULTS
Detection of reactions in vivo. To determine if the reactions depicted in Fig. 1 occur in vivo, radioactive substrates of each of the reactions were incubated with mycelial pad-sections. The data, reported in Table 1 , demonstrate that intact cells of the wild-type strain are capable of converting each substrate to the corresponding product. The inability of the pyr-4,uc-1,uc-3 strain to utilize thymine or 5-hydroxymethyluracil as substrate is consistent with the uc-3 mutation affecting reactions c and d (Fig.  1) . The data in Table 1 also indicate that the uc-2 mutation affects the conversions of thymidine and deoxyuridine to their respective ribonucleosides. In experiments 1 and 2, in which pad-sections of the wild-type and pyr-4,uc-1,uc-3 strains were incubated in the presence of nonradioactive nucleoside and pyrimidine traps (see Materials and Methods), thymidine and deoxyuridine were utilized to only small extents, but this utilization of the deoxyribonucleosides was found to be several-fold higher in other experiments (not shown in Table 1 ) in which the pad-sections were incubated in the absence of the traps. However, the utilization of deoxyribonucleosides by pad-sections of the uc-2-carrying strain was never observed to exceed 6%, even when the incubations were carried out in the absence of such traps. Furthermore, the results from experiment 3 in Table 1 indicate that the uc-2 mutation does not affect VOL. 121, 1975 the conversion of thymine ribonucleoside to thymine. This is consistent with growth studies which show that the pyr-4,uc-1,uc-2 strain can grow on thymine ribonucleoside as a sole pyrimidine source. However, when radioactive deoxycytidine was tested as a substrate for the 2'-hydroxylase reaction with intact cells, no radioactive cytidine was detected even when nonradioactive cytidine was added as a trap to the incubation mixture (Table 2) . Instead, deoxyuridine, uridine, and some uracil were formed, except with pad-sections of the ac-2-carrying strain in which case more deoxyuridine was formed but little, if any, uridine or uracil.
Direct conversion in vivo of thymidine to thymine ribonucleoside. To determine whether this conversion in whole cells involves free thymine as an intermediate, mycelial padsections of the wild-type strain, as well as of the two triple mutants, were incubated with [2-"C ]thymine in the presence and absence of nonradioactive thymine ribonucleoside. The formation of radioactive thymine ribonucleoside was not detected. Furthermore, in preliminary kinetic studies the free base could not be detected prior to the accumulation of the ribonucleoside when either radioactive thymidine or deoxyuridine were used as substrates with padsections of the wild-type and of the pyr-4,uc-1,uc-3 strains.
Additional support for this direct transformation of deoxyribose to ribose at the nucleoside level was obtained when pad-sections were incubated with thymidine which was uniformly labeled with "C and enriched in position 6 of the pyrimidine moiety with respect to 3H. Table  3 shows that the ratio of the specific activities of 3H to "C was the same for substrate and product. Moreover, this ratio was not changed when incubations were carried out in the presence of nonradioactive, potential intermediates, such as thymine.
Cell-free studies of the effects of the uc-2 and uc-3 mutations. Table 4 shows that the 2'-hydroxylase activity is much reduced in crude extracts of the uc-2-carrying strain. The uncentrifuged, homogenized mycelial preparations, from which these extracts were obtained, gave similar results although the assays of these homogenates exhibited less precision than those of the crude extracts. The 2-hydroxylase activity of the wild-type and pyr-4,uc-1,uc-3 strains was shown to be relatively constant throughout the growth period by experiments which involved the preparation of extracts from mycelia after 1 to 5 days of growth. Comparable studies of the 7-hydroxylase have shown that this activity does vary during the growth period and is affected by the degree of aeration during growth (11) , the composition of the growth medium, and the presence of the uc-l mutation (W. R. Griswold and M. T. Abbott, manuscript in preparation). However, under all conditions tested, the extracts prepared from the uc-3-carrying strain had no detectable 7-hydroxylase activity. When extracts of the wild-type strain and each of the two triple mutants were combined in various proportions and assayed, no inhibition could be detected, even when incubations were carried out with mixtures in which a Thirty-two nanomoles of thymidine, uniformly labeled with 14C and labeled with 'H in the 6 position, was incubated for 3 h with mycelial pad-sections of the pyr-4, uc-1, uc-3 strain as described in Material and Methods. The specific activities were determined as previously described (15) .
'Isolated after the incubation. The amounts of thymidine, thymine ribonucleoside, and thymine were 20.8, 5.0 and 7.8 nmol, respec ively.
c Isolated at zero time. (7) 6.7 ± 0.3 (2) 360 (6) 7-Hydroxylase Thymine 160 ± 77 (16) 368 ± 169 (6) 0 (8) aAssays were carried out in standard incubation mixtures with radioactive pyrimidine and nucleoside substrates.
The mean and standard deviation are given, with number of experiments in parentheses. Strain of N. crassa. the extract from the mutant was present in an amount three times that of the wild-type strain. In Table 5 data are presented from a typical experiment of this type. Similar results were obtained with the homogenates from which the crude extracts were derived. When the crude extract prepared from the pyr-4,uc-1 ,uc-2 strain was subjected to the purification scheme through the diethylaminoethyl-cellulose step as described by Liu et al. (10) , so that the 7-hydroxylase activity was purified 70-fold, no evidence was obtained for removal of a component which was inhibiting the 2'-hydroxylase activity. Similar results were obtained with respect to the 7-hydroxylase activity when extracts of the pyr-4,uc-1,uc-3 strain were subjected to the purification scheme through the ammonium sulfate step, as described by McCroskey et al. (11) , yet the purified preparation contained the anticipated 2'-hydroxylase activity.
Hydroxylation (Table  4 ). In addition, when the 2'-hydroxylase in several extracts from the wild-type strain was subjected to the purification scheme developed by Liu et al. (10) and assayed with both substrates, no separation of the activities was detected, and the ratio of specific activities appeared to be maintained. Likewise, this ratio was maintained during purification of the very low 2-hydroxylase activity of a single extract of the uc-2-carrying strain. In addition, preliminary kinetic studies carried out with purified 2'-hydroxylase fractions indicated that thymidine and deoxyuridine inhibit each other competitively. aThe 10,000 x g supernatant fraction was prepared from each strain as previously described (11) . Incubations were carried out in the standard incubation mixture. It consisted of 0.1 ml of extract or combinations of extracts and 0.1 ml of the buffer that contained the cofactors and substrate. The units of activity that were experimentally determined are recorded under "Experimental." The values in the "Predicted" column were calculated from the "Experimental" values determined in experiments 1 and 5. A second enzyme catalyzing the conversion of 5-formyluracil to uracil-5-carboxylic acid. When 5-formyluracil was used as substrate in the assay for 7-hydroxylase activity in crude preparations of the pyr-4,uc-1,uc-3 strain, no activity was detected, but such negative results are unconvincing since 5-formyluracil is only about one-fifth as effective a substrate as is thymine for the 7-hydroxylase (9), and it had frequently been difficult to demonstrate this activity in similar preparations from the wild type. Therefore, extracts of the 7-hydroxylase from the uc-3-carrying strain were purified with a calcium phosphate gel fractionation procedure and concentrated with ammonium sulfate (11) . These concentrates had easily demonstrable 2'-hydroxylase activity, but no activity was detected when thymine, 5-hydroxymethyluracil, or 5-formyluracil was used as substrate. However, the conversion of 5-formyluracil to uracil-5-carboxylic acid could easily be demonstrated in crude extracts of the uc-3-carrying strain when oxidized nicotinamide adenine dinucleotide was substituted for the cofactors of the standard incubation mixture (Fig. 2) . This suggests the possibility of two enzymes affecting this latter conversion, only one of which is active in the uc-3-carrying strain.
DISCUSSION
The utilization of each of the substrates and detection of the respective products (Table 1) of the reactions depicted in Fig. 1 are in accord with their occurring in vivo. The oxidative demethylation of thymine appears to occur primarily at the free base level since the same enzyme, thymine 7-hydrolyase, catalyzes reactions c, d, and e and the hydroxylation of neither thymidine nor thymine deoxyribonucleoside could be detected in vivo or in vitro (3). Since Neurospora lacks a thymidine phosphorylating enzyme (6, 7, 18) , this pathway provides a means of salvaging the pyrimidine ring of thymidine, but a source of ribose may still be required in order for the uracil end product to be converted to the nucleotide precursors of ribonucleic acid and deoxyribonucleic acid. Thus, the 2'-hydroxylase (Fig. 1, reaction a) allows the deoxyribose moiety also to be salvaged. The results obtained in vivo (Table 1 ) and in vitro (Table 4) indicate that the uc-2 mutation affects the 2 -hydroxylase. Although the data in Table 1 suggest that the pvr-4,uc-l,uc-2 strain is much less effective in catalyzing reactions c, d, and e (Fig. 1) than is the wild-type strain, the cell-free studies (Table 4) indicate that this lower activity is not a consequence of less thymine 7-hydroxylase being present. Perhaps the pyr-4-carrying mutants (which lack orotidylate decarboxylase [13] ) are less effective in the uptake of pyrimidines. Preliminary experiments with the pyr-4 strain and pyr-4,uc-1 strain (developed by Williams and Mitchell [18] and recently isolated by W. R. Griswold) have shown that the extent to which these strains metabolize thymine is much less than that of the wild type and similar to that of the pyr-4,uc-1,uc-2 strain. Although the pyr-4,uc-1,uc-2 strain has a much reduced 2'-hydroxylase activity, a small amount of this activity did appear to be detected in this strain. It is noteworthy that the uc-2 mutation blocked not only the utilization of thymine but also of deoxycytidine and deoxyuridine, and thus it would appear that Neurospora is deficient in its capacity to phosphorylate all of the common pyrimidine deoxyribonucleosides. This finding is consistent with data of Williams and Mitchell (18) which showed that a small amount of thymidine was incorporated into the nucleic acids of this strain. Studies carried out both in vivo (Table 1) and in vitro (Table 4) showed that the uc-3-carrying mutant does not contain an active thymine 7-hydroxylase. However, the data of Table 1 demonstrated that intact cells of the uc-3-carrying strain can convert 5-formyluracil to uracil-5-carboxylic acid, an observation which can apparently be explained by the presence in Neurospora of an additional enzyme which can convert 5-formyluracil to uracil-5-carboxylic acid (Fig. 2) .
